|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 9/16 | |
| C12N 15/861 | |||
| A61K 48/00 | |||
| A61K 38/00 |
| (11) | Patento numeris | 2510091 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10801023.2 |
| Europos patento paraiškos padavimo data | 2010-12-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-10-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-06-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/059204 |
| Data | 2010-12-07 |
| (87) | Numeris | WO 2011/071859 |
| Data | 2011-06-16 |
| (30) | Numeris | Data | Šalis |
| 283696 P | 2009-12-08 | US |
| (72) |
KOLESNICK, Richard, N., US
STANCEVIC, Branka, US
SADELAIN, Michel, US
FUKS, Zvi, US
VARDA-BLOOM, Nira, IL
HARATS, Dror, IL
|
| (73) |
Vascular Biogenics Ltd.,
6 Jonathan Netanyahu Street, 60376 Or Yehuda,
IL
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, US |
| (54) | METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS |
| METHOD AND COMPOSITION TO INCREASE RADIATION-INDUCED TUMOR THERAPEUTIC EFFECTS |